Once the product is launched in Q2 2016, Beteflam is expected to be our fourth marketed product in Canada behind Epuris, Vaniqa
, and Actikerall(TM).
SkinMedica's primary prescription product is VANIQA
(eflornithine hydrochloride) Cream, 13.
The purchase agreement involved the acquisition by Women's First Healthcare of product rights, trademarks, patents, and legal filings for Vaniqa
cream, as well as all related products, and over-the-counter rights.
Food and Drug Administration (FDA) approved Vaniqa
(eflornithine hydrochloride), a prescription medication cream that reduces unwanted facial hair.
A dermatologist can prescribe Vaniqa
to thwart growth, but it doesn't work for everyone, explains Dr.
Mathes ran the clinical trials of Vaniqa
, a drug that slows hair growth by interfering with the formation of amino acids needed for cell growth.
is a prescription drug approved for the cosmetic treatment of unwanted facial hair in women.
In 2007 the Group divested a portfolio of non-core products, including SOLARAZE and VANIQA
, to Laboratorios Almirall ('Almirall') and sold EQUETRO and transferred post-approval study commitments to Validus Pharmaceuticals Inc.
9% cream under the trade name Vaniqa
by Bristol-Myers Squibb and the Gillette Co.
The firm also manufactures Vaniqa
Cream, the only FDA-approved prescription product for the reduction of unwanted facial hair in women.
3TC (lamivudine) (trademarks of GlaxoSmithKline (GSK)) COMBIVIR (lamivudine) (trademark of GSK) DYNEPO (epoetin delta) (trademark of Sanofi Aventis) EPIVIR (lamivudine) (trademark of GSK) EPZICOM (lamivudine) (trademark of GSK) JUVISTA (trademark of Renovo) PENTASA (mesalamine) (trademark of Ferring) RAZADYNE (galantamine) (trademark of Johnson & Johnson) RAZADYNE ER (galantamine) (trademark of Johnson & Johnson) REMINYL (galantamine) (trademark of Johnson & Johnson, excluding UK and Republic of Ireland) REMINYL XL (galantamine) (trademark of Johnson & Johnson, excluding UK and Republic of Ireland) SOLARAZE (diclofenac sodium (3%w/w)) (trademark of Almirall) VANIQA
(eflornithine hydrochloride) (trademark of Almirall) ZEFFIX (lamivudine) (trademark of GSK)
Because there are no studies in pregnant women, the risk-benefit ratio of using Vaniqa
during pregnancy "should be weighed carefully with serious consideration for either not implementing or discontinuing" the use of the product, the labeling says.